CYCLERION THERAPEUTICS, INC. Additional Paid in Capital, Common Stock
CYCLERION THERAPEUTICS, INC. (CYCN) had Additional Paid in Capital, Common Stock of $281.04 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-04
- 2026-06-30: Additional Paid in Capital, Common Stock $281.04M.
- 2026-03-31: Additional Paid in Capital, Common Stock $280.99M.
- 2025-12-31: Additional Paid in Capital, Common Stock $280.11M.
- 2025-09-30: Additional Paid in Capital, Common Stock $279.76M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2026-06-30 | $281.04M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $280.99M S-4/A · filed 2026-07-22 |
| 2025-12-31 | $280.11M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $279.76M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $277.81M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $277.70M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $276.34M S-4/A · filed 2026-07-22 |
| 2024-09-30 | $276.22M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $276.08M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $275.90M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $275.72M 10-K/A · filed 2025-11-12 |
| 2023-09-30 | $275.61M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $275.45M 10-Q · filed 2023-07-28 |
| 2023-03-31 | $270.05M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $269.63M 10-K · filed 2024-03-05 |
| 2022-09-30 | $268.49M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $266.83M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $265.11M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $263.35M 10-K · filed 2023-03-22 |
| 2021-09-30 | $260.71M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $258.26M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $225.29M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $222.95M 10-K · filed 2022-02-24 |
| 2020-09-30 | $219.58M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $191.52M 10-Q · filed 2020-08-03 |
| 2020-03-31 | $187.41M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $183.38M 10-K · filed 2021-02-25 |
| 2019-09-30 | $178.77M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $173.45M 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |